Celadon Pharmaceuticals

Celadon Pharmaceuticals is a UK-based pharmaceutical company dedicated to the research, cultivation, manufacturing, and supply of cannabinoid medicines. Its primary focus is improving the quality of life for patients with chronic pain, as well as exploring the potential of cannabinoid treatments for other conditions such as autism. Its facilities in the UK include a laboratory designed to meet UK-GMP standards and a large-scale indoor hydroponic cultivation facility that has received a Home Office license to legally grow high-THC medicinal cannabis for the production of test batches of cannabis oil to support its application to the MHRA.